Tag: pharma QA

Addressing Label Claim Mismatches in Nutraceutical Manufacturing: Strategies for Risk Mitigation Label claim mismatches present significant challenges in the nutraceutical manufacturing sector, particularly concerning regulatory compliance and consumer safety. Such…

Addressing cGMP Non-Compliance Observations during Shelf-Life Studies Non-compliance with current Good Manufacturing Practices (cGMP) during shelf-life studies can lead to critical regulatory consequences, impact product efficacy, and compromise patient safety.…

“`html Resolving Ingredient Identity Failures in Nutraceutical Manufacturing: Enhancing Quality Systems Ingredient identity failures can pose significant risks in nutraceutical manufacturing, jeopardizing product quality and regulatory compliance. These failures manifest…

“`html Addressing Ingredient Identity Failures During Market Complaint Reviews: A Focus on Regulatory Risk Mitigation Ingredient identity failure in the realm of nutraceuticals and dietary supplements can lead to significant…

Addressing Label Claim Discrepancies Uncovered During FDA Inspections Label claim mismatches represent significant compliance concerns for pharmaceutical and nutritional supplement manufacturers. These discrepancies can lead to serious regulatory actions during…

“`html Addressing Stability Issues in Nutraceuticals: A Structured Approach to Market Complaints The stability degradation of products can pose significant challenges for pharmaceutical manufacturers, particularly during market complaint reviews. These…

Quality System Upgrades: Investigating Stability Degradation During FDA Inspections Stability degradation during FDA inspections can pose significant risks to pharmaceutical manufacturing processes, particularly in nutraceuticals and dietary supplements. Such a…